Suven
Life Sciences has been granted one product patent from Japan and one from USA
corresponding to the New Chemical Entities (NCEs) for the treatment of
disorders associated with Neurodegenerative diseases and these patents are
valid through 2028 & 2029. With these new patents, the company has a total
of six granted patents from Japan and, twelve granted product patents from USA.
Get Free MCX Tips, Stock Tips, Forex Tips & NCDEX Tips,Commodity Tips, Share Tips, commodity tips free trial, nifty free tips, commodity trading tips, shares tips, Share Market Tips, Stock Market Tips, free stock tips on mobile, Stock trading tips, Intraday Tips. or login http://www.epicresearch.co/
No comments:
Post a Comment